Biohaven Ltd (BHVN) Stock Price, Quote & News

Company Profile

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide. The company develops troriluzole, which is in Phase 3 trial for the treatment of neurological and neuropsychiatric illnesses; taldefgrobep alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 3 clinical trial for the treatment of focal and generalized epilepsy, and major depressive disorder; BHV-2100 tha...

Industry: Biotechnology

Sector: Healthcare

Phone: 203 404 0410

Website: www.biohaven.com

Address:

215 Church Street, New Haven, United States

judgeyoung2 Jul. 16 at 6:00 PM

$GRI $DMAC $BHVN $LLY $MTSR all of these are supposed to have data coming soon 🧐

1 · Reply

Stayinvest Jul. 16 at 4:52 PM

$BHVN I’m invested with my own money no broker will force me to sale in a lost. Not this time like they did on 2022. And look we’re Palantir is. Morgan Stanley had the price target at 9 by them. Totally wrong. Still wrong

0 · Reply

ChrisBAB Jul. 16 at 4:38 PM

$BHVN Added more. Its time will come.

1 · Reply

zoyjr Jul. 16 at 4:32 PM

$BHVN filed yesterday but: https://www.globenewswire.com/news-release/2025/07/15/3115822/10782/en/Gainey-McKenna-Egleston-Announces-a-Class-Action-Lawsuit-Has-Been-Filed-Against-Biohaven-Ltd-BHVN.html

0 · Reply

knowthyself Jul. 16 at 3:38 PM

$BHVN we're gonna see 12s today. I remember way back when the share price was at 12 before its glorious run

1 · Reply

Thr0winDarts Jul. 16 at 3:37 PM

$BHVN every day we get silence is worse and worse

0 · Reply

Robcat Jul. 16 at 3:25 PM

$BHVN Set my second buy order at 13 today. Break or bust!

0 · Reply

Robcat Jul. 16 at 1:59 PM

$BHVN Add more today. As a retailer, I have already accumulated enough shares of BHVN now. Let's go!

0 · Reply

RideDaLightning Jul. 16 at 10:16 AM

$BHVN there is an old saying in the streets… “Scared money don’t make money son “. This thing is gonna print for all of us.. hold tight playa

0 · Reply

Quantumup Jul. 16 at 10:02 AM

Citizens reiterated $RAPP Market Outperform-$28 after a KOL call reinforced its confidence in the pot'l for positive RAP-219 Phase 2 results in focal epilepsy. $PRAX $XENE $BHVN $NBIX TAK UCBJY Citizens said in its note: "We recently hosted Dr. Vikram Rao, a neurologist from UCSF and epilepsy KOL, for a discussion on the upcoming Phase 2 proof-of-concept results for RAP-219 in focal epilepsy. Dr. Rao is optimistic about the potential for RAP-219 in focal epilepsy due to its validated yet differentiated mechanism of action, compelling preclinical results, and innovative Phase 2 trial design. RAPP remains one of our two high-conviction calls into the Phase 2 results in September."

0 · Reply

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. (BHVN)

Jun 10, 2025, 2:00 PM EDT - 5 weeks ago

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

May 29, 2025, 7:01 AM EDT - 6 weeks ago

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

May 28, 2025, 3:00 PM EDT - 7 weeks ago

Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)

May 28, 2025, 7:30 AM EDT - 7 weeks ago

Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors

May 15, 2025, 1:22 PM EDT - 2 months ago

Why Is Biohaven Stock Falling On Thursday?

May 14, 2025, 6:43 PM EDT - 2 months ago

FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia

May 12, 2025, 4:05 PM EDT - 2 months ago

Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments

May 5, 2025, 8:00 AM EDT - 2 months ago

Biohaven Is Now A Compelling Contrarian Play Before Troriluzole's FDA Verdict

Apr 28, 2025, 7:30 AM EDT - 2 months ago

Biohaven Announces Investment up to $600 Million by Oberland Capital

Apr 15, 2025, 9:10 AM EDT - 3 months ago

BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm

Apr 5, 2025, 9:00 AM EDT - 3 months ago

Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting

Mar 27, 2025, 7:40 AM EDT - 3 months ago

Biotech stocks have been hit hard. Why they're a great value now.

PFE DNLI GPCR INSM MRK SWTX

Mar 20, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Bronstein, Gewirtz & Grossman, LLC (BHVN) and Encourages Stockholders to Learn More About the Investigation

Mar 19, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Shareholders to Learn More About the Investigation

Mar 18, 2025, 10:00 AM EDT - 4 months ago

Biohaven Ltd. (BHVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Mar 17, 2025, 1:30 PM EDT - 4 months ago

Biohaven Ltd. Being Investigated on Behalf of Biohaven Ltd.

Mar 17, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Shareholders to Inquire about Securities Investigation

Mar 16, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Shareholders to Connect

Mar 14, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Investors to Connect

Mar 13, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Stockholders to Inquire about Securities Investigation

Mar 12, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Investors to Learn More About the Investigation

Mar 11, 2025, 10:00 AM EDT - 4 months ago

Biohaven Ltd. (BHVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

judgeyoung2 Jul. 16 at 6:00 PM

$GRI $DMAC $BHVN $LLY $MTSR all of these are supposed to have data coming soon 🧐

1 · Reply

Stayinvest Jul. 16 at 4:52 PM

0 · Reply

ChrisBAB Jul. 16 at 4:38 PM

$BHVN Added more. Its time will come.

1 · Reply

zoyjr Jul. 16 at 4:32 PM

0 · Reply

knowthyself Jul. 16 at 3:38 PM

$BHVN we're gonna see 12s today. I remember way back when the share price was at 12 before its glorious run

1 · Reply

Thr0winDarts Jul. 16 at 3:37 PM

$BHVN every day we get silence is worse and worse

0 · Reply

Robcat Jul. 16 at 3:25 PM

$BHVN Set my second buy order at 13 today. Break or bust!

0 · Reply

Robcat Jul. 16 at 1:59 PM

$BHVN Add more today. As a retailer, I have already accumulated enough shares of BHVN now. Let's go!

0 · Reply

RideDaLightning Jul. 16 at 10:16 AM

$BHVN there is an old saying in the streets… “Scared money don’t make money son “. This thing is gonna print for all of us.. hold tight playa

0 · Reply

Quantumup Jul. 16 at 10:02 AM

0 · Reply

sellthedip1 Jul. 15 at 11:26 PM

$BHVN oh no the bears 😂really wow great insight

1 · Reply

Thr0winDarts Jul. 15 at 10:53 PM

$BHVN OCD trial will fail. The P2 they did was not impressive and other studies with Riluzole for OCD were inconclusive as well

1 · Reply

Lastcall Jul. 15 at 10:20 PM

$BHVN Who's the DK Head that keeps buying the 1 share ask to keep the fake price up

0 · Reply

Reneejordan001 Jul. 15 at 9:21 PM

$BHVN They just initiated another clinical trial for iga nephropathy. 👇 https://clinicaltrials.gov/study/NCT07054684?term=AREA%5BBasicSearch%5D(AREA%5BBasicSearch%5D(biohaven))&rank=7

0 · Reply

Darth_Barrister Jul. 15 at 8:07 PM

$BHVN I am surprised the share price has held up given the silence of the company on OCD. Today was not great, but I would have thought we would be at $10 right now after the promised deadline for OCD passed without a word. Maybe that portends something good on the horizon(?).

1 · Reply

sellthedip1 Jul. 15 at 8:02 PM

$BHVN feels like a news day 🙃👏

1 · Reply

shockcityrocker Jul. 15 at 8:02 PM

$BHVN I bought a metric butt-ton of this today 😎

1 · Reply

Lastcall Jul. 15 at 7:10 PM

$BHVN Inflation is going to continue to rise it's not rocket science

0 · Reply

sellthedip1 Jul. 15 at 6:50 PM

$BHVN not gonna lie today hurts..down a lot never feels good…but one day things be different 🫤

1 · Reply

sellthedip1 Jul. 15 at 6:37 PM

$BHVN buying more on this weakness . All small caps are down this is a draw down due to higher inflation data.

0 · Reply

knowthyself Jul. 15 at 4:59 PM

$BHVN a "lawsuit" has been filed, the typical ambulance chaser bs. That might be causing the weakness.

0 · Reply

shockcityrocker Jul. 15 at 4:31 PM

$BHVN Added a weeeee bit.

0 · Reply

Market Cap	1.45B
Revenue (ttm)	0.00
Net Income (ttm)	-846.42M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,224,517
Avg Vol	2,091,540
Day's Range	N/A - N/A
Shares Out	102.11M
Stochastic %K	1%
Beta	0.91
Analysts	Strong Sell
Price Target	$53.64